Page 99 - Read Online

Page 18 of 20 Ottewell et al. J Cancer Metastasis Treat 2021;7:11 https://dx.doi.org/10.20517/2394-4722.2021.14

Copyright
© The Author(s) 2021.

REFERENCES
1. Salvador F, Llorente A, Gomis RR. From latency to overt bone metastasis in breast cancer: potential for treatment and prevention. J
Pathol 2019;249:6-18. DOI PubMed PMC
2. George CN, Canuas-Landero V, Theodoulou E, Muthana M, Wilson C, Ottewell P. Oestrogen and zoledronic acid driven changes to
the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre-
and post-menopausal conditions. J Bone Oncol 2020;25:100317. DOI PubMed PMC
3. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature
2007;449:682-8. DOI PubMed
4. Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell
Biol 2008;10:202-10. DOI PubMed
5. Cox TR, Rumney RMH, Schoof EM, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.
Nature 2015;522:106-10. DOI PubMed PMC
6. Tulotta C, Lefley DV, Freeman K, et al. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization
of the Bone Microenvironment. Clin Cancer Res 2019;25:2769-82. DOI PubMed
7. Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature 2016;529:298-306. DOI PubMed PMC
8. Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011;11:411-25. DOI PubMed PMC
9. Hess KR, Pusztai L, Buzdar AU, Hortobagyi GN. Estrogen Receptors and Distinct Patterns of Breast Cancer Relapse. Breast Cancer
Res Treat 2003;78:105-18. DOI PubMed
10. Goss PE, Chambers AF. Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 2010;10:871-7. DOI PubMed
11. Tahara RK, Brewer TM, Theriault RL, Ueno NT. Bone Metastasis of Breast Cancer. In: Ahmad A, editor. Breast Cancer Metastasis
and Drug Resistance. Cham: Springer International Publishing; 2019. pp. 105-29.
12. Owen KL, Parker BS. Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in
dictating bone metastasis. Mol Immunol 2019;110:57-68. DOI PubMed
13. Ottewell PD. The role of osteoblasts in bone metastasis. J Bone Oncol 2016;5:124-7. DOI PubMed PMC
14. Heilmann T, Rumpf AL, Roscher M, et al. Dasatinib prevents skeletal metastasis of osteotropic MDA-MB-231 cells in a xenograft
mouse model. Arch Gynecol Obstet 2020;301:1493-502. DOI PubMed
15. Bellahcène A, Bachelier R, Detry C, Lidereau R, Clézardin P, Castronovo V. Transcriptome analysis reveals an osteoblast-like
phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat 2007;101:135-48. DOI PubMed
16. Eyre R, Alférez DG, Santiago-Gómez A, et al. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone
via activation of Wnt signalling. Nat Commun 2019;10:5016. DOI PubMed PMC
17. Tulotta C, Groenewoud A, Snaar-jagalska BE, Ottewell P. Animal Models of Breast Cancer Bone Metastasis. In: Idris AI, editor. Bone
Research Protocols. New York: Springer; 2019. pp. 309-30.
18. Ottewell PD, Deux B, Mönkkönen H, et al. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous
breast tumor growth in vivo. Clin Cancer Res 2008;14:4658-66. DOI PubMed
19. Nutter F, Holen I, Brown HK, et al. Different molecular profiles are associated with breast cancer cell homing compared with
colonisation of bone: evidence using a novel bone-seeking cell line. Endocr Relat Cancer 2014;21:327-41. DOI PubMed
20. Reed ND, Manning DD. Long-term maintenance of normal human skin on congenitally athymic (nude) mice. Proc Soc Exp Biol Med
1973;143:350-3. DOI PubMed
21. Zhang X, Lewis MT. Establishment of Patient-Derived Xenograft (PDX) Models of Human Breast Cancer. Curr Protoc Mouse Biol
2013;3:21-9. DOI PubMed
22. Kanaya N, Somlo G, Wu J, et al. Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive
(ER+HER2- and ER+HER2+) breast cancers. J Steroid Biochem Mol Biol 2017;170:65-74. DOI PubMed PMC
23. Lefley D, Howard F, Arshad F, et al. Development of clinically relevant in vivo metastasis models using human bone discs and breast
cancer patient-derived xenografts. Breast Cancer Res 2019;21:130. DOI PubMed PMC
24. Okada S, Vaeteewoottacharn K, Kariya R. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived
Xenograft (PDX) Models. Cells 2019;8:889. DOI PubMed PMC
25. Han Y, Nakayama J, Hayashi Y, et al. Establishment and characterization of highly osteolytic luminal breast cancer cell lines by
intracaudal arterial injection. Genes Cells 2020;25:111-23. DOI PubMed
26. Yi B, Williams PJ, Niewolna M, Wang Y, Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in
osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 2002;62:917-23. PubMed
27. Isoda T, BaBa S, Maruoka Y, et al. Influence of the Different Primary Cancers and Different Types of Bone Metastasis on the Lesion-
based Artificial Neural Network Value Calculated by a Computer-aided Diagnostic System, BONENAVI, on Bone Scintigraphy
Images. Asia Ocean J Nucl Med Biol 2017;5:49-55. DOI PubMed PMC
28. Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic
cells support selective colonization of breast cancer cells in bone. Int J Oncol 2008;33:17-24. PubMed
29. Pécheur I, Peyruchaud O, Serre CM, et al. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize
to bone. FASEB J 2002;16:1266-8. DOI PubMed